BBlogFlow

Collision near Boundary Trails Health Centre backs up traffic - PembinaValleyOnline

·Aug 28, 2026
Source: PembinaValleyOnline
Read the original article

This story deserves to be shared

Send it to someone who'd care, or post it on your networks.

Facebook Twitter Email

This article is an excerpt. To read the full content, visit the original source. PembinaValleyOnline

Reactions

0 comments

No comments yet. Be the first to share your thoughts!

Facebook Twitter

Related articles

New pharmacy marks another milestone in Boundary Trails Health Centre expansion - mySteinbach.ca

Another important piece of the Boundary Trails Health Centre (BTHC) expansion is opening its doors, as the hospital’s pharmacy team begins moving into its new space in October, 2026. The new hospital pharmacy represents another significant milestone in the ongoing expansion and redevelopment of BTHC – an investment designed to strengthen health-care services and increase capacity for residents of the Morden and Winkler area.

mySteinbach.ca·

Patient-centered financial navigation assistance helps reduce financial toxicity among cancer patients - Medical Xpress

Among cancer patients, the high financial cost of cancer care is a prevalent problem. This financial burden is also associated with potentially harmful behavioral strategies that patients might use to cope with costs, such as delaying or forgoing treatment and skipping medications. Collectively, researchers refer to this impact as financial toxicity.

Medical Xpress·

Continuous glucose monitors help type 2 diabetes patients spend 5 more hours a day in healthy blood sugar range - Medical Xpress

Continuous glucose monitors (CGMs) could transform diabetes management for millions of Americans with type 2 diabetes who don't take insulin, according to findings published in the New England Journal of Medicine. The clinical trial found that adults using CGMs spent approximately five additional hours each day within their target blood sugar range compared with those receiving routine care. Nearly twice as many CGM users also achieved an A1c level below 7%, a common treatment goal for people with diabetes.

Medical Xpress·

Kefah Mokbel: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? - Oncodaily

“Beyond Detecting Cancer Recurrence: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? An exciting new study published in The Oncologist highlights the clinical potential of Signatera Genome, a whole-genome sequencing (WGS)-based, tumor-informed circulating tumor DNA (ctDNA) assay, not only for detecting molecular residual disease (MRD), but also for potentially informing adjuvant treatment decisions.

Oncodaily·